In August 2025, the US Food and Drug Administration (FDA) approved Tonmya ® (cyclobenzaprine hydrochloride sublingual tablets; Tonix Pharmaceuticals) for the treatment of fibromyalgia in adults. Study ...
A novel formulation of the muscle relaxant drug cyclobenzaprine has won FDA approval for treating fibromyalgia, manufacturer Tonix Pharmaceuticals announced on Friday. To be sold as Tonmya, the ...
TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback